메뉴 건너뛰기




Volumn 132, Issue 5, 2006, Pages 320-326

Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer

Author keywords

5 Fluorouracil; Colorectal cancer; Oxaliplatin; Pharmacokinetics

Indexed keywords

CREATININE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PLATINUM;

EID: 33644535150     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0072-6     Document Type: Article
Times cited : (4)

References (25)
  • 1
    • 0031561774 scopus 로고    scopus 로고
    • Simultaneous gas chromatographic-mass spectrophotometric determination of alpha-fluoro-beta-alanine and 5-fluorouracil in plasma
    • Anderson D, Kerr DJ, Blesing C, Seymour LW (1997) Simultaneous gas chromatographic-mass spectrophotometric determination of alpha-fluoro-beta- alanine and 5-fluorouracil in plasma. J Chromatogr B Biomed Sci Appl 688:87-93
    • (1997) J Chromatogr B Biomed Sci Appl , vol.688 , pp. 87-93
    • Anderson, D.1    Kerr, D.J.2    Blesing, C.3    Seymour, L.W.4
  • 2
    • 0031838984 scopus 로고    scopus 로고
    • Oxaliplatin plus 5-fluorouracil: Clinical experience in patients with advanced colorectal cancer
    • Bleiberg H, de Granmont A (1998) Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer. Semin Oncol 25:32-39
    • (1998) Semin Oncol , vol.25 , pp. 32-39
    • Bleiberg, H.1    De Granmont, A.2
  • 4
    • 0242720707 scopus 로고    scopus 로고
    • Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer
    • Cattel L, La Grotta G, Infante L, Passera R, Arpicco S, Brusa P, Bumma C (2003) Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer. Farmaco 58:1333-1338
    • (2003) Farmaco , vol.58 , pp. 1333-1338
    • Cattel, L.1    La Grotta, G.2    Infante, L.3    Passera, R.4    Arpicco, S.5    Brusa, P.6    Bumma, C.7
  • 5
    • 33644549883 scopus 로고    scopus 로고
    • Prevalence of the IVS14 + IG > a mutation of dihydropyrimidine dehydrogenase gene
    • Chang HM, Kim TW, Ryu MH, Lee H (2004) Prevalence of the IVS14 + IG > A mutation of dihydropyrimidine dehydrogenase gene. Cancer Res Treat 36(Suppl 1):42
    • (2004) Cancer Res Treat , vol.36 , Issue.1 SUPPL. , pp. 42
    • Chang, H.M.1    Kim, T.W.2    Ryu, M.H.3    Lee, H.4
  • 6
    • 0033766638 scopus 로고    scopus 로고
    • Oxaliplatin: A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies
    • Culy CR, Clemett D, Wiseman LR (2000) Oxaliplatin: a review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drug 60:895-924
    • (2000) Drug , vol.60 , pp. 895-924
    • Culy, C.R.1    Clemett, D.2    Wiseman, L.R.3
  • 7
    • 0031890613 scopus 로고    scopus 로고
    • Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis
    • Etienne MC, Chatelut E, Pivot X, Lavit M, Pujol A, Canal P, Milano G (1998) Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis. Eur J Cancer 34:92-97
    • (1998) Eur J Cancer , vol.34 , pp. 92-97
    • Etienne, M.C.1    Chatelut, E.2    Pivot, X.3    Lavit, M.4    Pujol, A.5    Canal, P.6    Milano, G.7
  • 13
    • 0025058867 scopus 로고
    • Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion
    • Harris BE, Song R, Soong SJ, Diasio RB (1990) Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 50:197-201
    • (1990) Cancer Res , vol.50 , pp. 197-201
    • Harris, B.E.1    Song, R.2    Soong, S.J.3    Diasio, R.B.4
  • 16
    • 0041055512 scopus 로고    scopus 로고
    • Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil and folinic acid in metastatic colorectal cancer
    • Levi F, Zidani R, Misset JL (1997b) Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil and folinic acid in metastatic colorectal cancer. Lancet 350:681-686
    • (1997) Lancet , vol.350 , pp. 681-686
    • Levi, F.1    Zidani, R.2    Misset, J.L.3
  • 19
    • 0036020649 scopus 로고    scopus 로고
    • Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics
    • Mattison LK, Soong R, Diasio RB (2002) Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics. Pharmacogenomics 3:485-492
    • (2002) Pharmacogenomics , vol.3 , pp. 485-492
    • Mattison, L.K.1    Soong, R.2    Diasio, R.B.3
  • 20
    • 0034808681 scopus 로고    scopus 로고
    • Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5′-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls
    • Raida M, Schwabe W, Hausler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Hoffken K (2001) Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5′-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls. Clin Cancer Res 7:2832-2839
    • (2001) Clin Cancer Res , vol.7 , pp. 2832-2839
    • Raida, M.1    Schwabe, W.2    Hausler, P.3    Van Kuilenburg, A.B.4    Van Gennip, A.H.5    Behnke, D.6    Hoffken, K.7
  • 22
    • 0002963473 scopus 로고
    • Quantitation of platinum - DNA binding in human tissues following therapeutic levels of drug exposure
    • Reed E, Sauerhoff S, Poirier MC (1988) Quantitation of platinum - DNA binding in human tissues following therapeutic levels of drug exposure. Atom Spectrosc 9:93-95
    • (1988) Atom Spectrosc , vol.9 , pp. 93-95
    • Reed, E.1    Sauerhoff, S.2    Poirier, M.C.3
  • 23
    • 0000460127 scopus 로고    scopus 로고
    • Oxaliplatin, tetraplatin, cisplatin and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of National Cancer Institutes's Anticancer Drug Screen Panel
    • Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T (1996) Oxaliplatin, tetraplatin, cisplatin and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of National Cancer Institutes's Anticancer Drug Screen Panel. Biochem Pharmacol 52:1855-1865
    • (1996) Biochem Pharmacol , vol.52 , pp. 1855-1865
    • Rixe, O.1    Ortuzar, W.2    Alvarez, M.3    Parker, R.4    Reed, E.5    Paull, K.6    Fojo, T.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.